BuyCancerDrugs.com BuyCancerDrugs.com
BuyCancerDrugs.com BuyCancerDrugs.com
OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer
Search OncologyJournal.org
Browse by Cancer Type or Cancer Drug

Go Back   OncologyJournal.org - The Latest Medical News and Information for Patients Diagnosed with Cancer > Blogs > admin
Connect with Facebook


Bexxar (Tositumomab)
Old

Pat. W/ Indolent Lymphomas Exhibit Long-Term Surv. W/ Tositumomab Aft Rituximab Fail.

Posted 12-16-2009 at 02:17 PM by admin
Patients With Indolent Lymphomas Exhibit Long-Term Survival With Tositumomab After Rituximab Failure: Presented at ASH

Doctor's Guide
DGDispatch

By Ed Susman

NEW ORLEANS -- December 9, 2009 -- Patients whose indolent lymphoma has progressed following treatment with rituximab may achieve long-term survival with follow-up therapy with a tositumomab and iodine I131 tositumomab therapeutic regimen, researchers stated here at the American Society of Hematology...
Administrator
Comments 0 admin is offline


All times are GMT. The time now is 05:12 PM.


Powered by vBulletin® Version 3.8.1
Copyright ©2000 - 2010, Jelsoft Enterprises Ltd.